Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21.2M Buy
143,890
+8,960
+7% +$1.31M 0.1% 180
2025
Q4
$16.4M Buy
134,930
+23,150
+21% +$2.72M 0.09% 214
2025
Q3
$12.1M Buy
111,780
+22,330
+25% +$2.08M 0.08% 237
2025
Q2
$8.03M Buy
89,450
+42,330
+90% +$3.18M 0.06% 272
2025
Q1
$3.18M Buy
47,120
+9,130
+24% +$658K 0.03% 404
2024
Q4
$2.49M Buy
37,990
+1,020
+3% +$68.9K 0.03% 426
2024
Q3
$2.86M Buy
36,970
+22,340
+153% +$1.75M 0.06% 296
2024
Q2
$1.21M Buy
14,630
+7,390
+102% +$546K 0.05% 300
2024
Q1
$506K Buy
7,240
+3,030
+72% +$195K 0.07% 267
2023
Q4
$240K Buy
+4,210
New +$219K 0.06% 244

Other funds holding KLAC

&Partners's KLAC Position: Q1 2026 in Review

&Partners increased its KLA (KLAC) stake by 6.6% in Q1 2026, buying an estimated $1.31M and bringing the position to 143,890 shares worth $21.2M. The position accounts for 0.1% of the portfolio, ranked #180.

&Partners first reported a position in KLAC in Q4 2023 and has held it in 10 quarters since. 2,063 funds tracked by Wall St. Rank hold KLAC as of Q1 2026.

  • &Partners held 143,890 shares of KLA worth $21.2M as of Q1 2026.
  • &Partners bought 8,960 KLA shares in Q1 2026, an estimated $1.31M.
  • KLA made up 0.1% of &Partners's portfolio in Q1 2026, its #180 holding.
  • &Partners first reported a position in KLA in Q4 2023 and has held it in 10 quarters since.
  • 2,063 funds tracked by Wall St. Rank held KLA as of Q1 2026.

Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.